Wataru Morikawa

Title: Wataru Morikawa: Innovator in Medical Biotechnology

Introduction

Wataru Morikawa is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical biotechnology, particularly in the development of methods for detecting thrombosis and monomerizing specific proteins. With a total of two patents to his name, Morikawa's work has the potential to impact medical diagnostics and treatments.

Latest Patents

Morikawa's latest patents include a "Method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregate." This innovative method involves treating MMP-7 aggregates with a buffer solution containing a monovalent cation chloride at low concentrations or with a buffer solution that does not contain such cations. Additionally, he has developed a "Method of detecting thrombosis by measuring von Willebrand factor-cleaving protease." This method provides a convenient, rapid, and specific way to detect thrombosis or the degree of thrombophilia, along with a corresponding detection kit.

Career Highlights

Throughout his career, Wataru Morikawa has worked with prominent companies in the biotechnology sector, including Mitsubishi Kagaku Iatron, Inc. and Km Biologics Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical technology.

Collaborations

Morikawa has collaborated with notable colleagues such as Masaki Hirashima and Tomoko Ono. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Wataru Morikawa stands out as an influential inventor in the field of medical biotechnology. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.